Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolargo Inc (OP: BLGO )

0.3089 +0.0100 (+3.35%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Biolargo Inc

< Previous 1 2 3 4 Next >
BioLargo Annual Report Highlights 132% Annual Revenue Increase, Reduced Net Loss
Via ACCESSWIRE
BioLargo, Inc. Discusses 125% Revenue Increase and Significance of Proposed EPA PFAS Regulations with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - March 29, 2023) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) (the "Company"), a... 
Via Newsfile
BioLargo 2022 Annual Earnings Results Webcast and Conference Call on Monday, April 3, 2023 - 4:30 PM Eastern Time
Via ACCESSWIRE
BioLargo Acquires Rights to Sodium-Sulfur Battery Energy Storage Technology
Via ACCESSWIRE
BioLargo Continues Record Setting Revenue Growth
Via ACCESSWIRE
BioLargo to Appear on ClearThink IR's Virtual Live Event on Wednesday, January 25, 2023 at 12 Noon ET
Via ACCESSWIRE
BioLargo's Partner Ikigai Begins Sales of Pooph at Walmart
Via ACCESSWIRE
BioLargo's PFAS Treatment Technology Meets EPA's Proposed New Drinking Water Standards
Via ACCESSWIRE
BioLargo Subsidiary Clyra Medical Technologies Adds Two Medical Industry Veterans to its Board of Directors
Via ACCESSWIRE
BioLargo, Inc. Discusses 125% Revenue Increase for 2022 with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 31, 2023) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that... 
Via Newsfile
BioLargo Grew 2022 Revenue by More Than 125% Over the Prior Year
Via ACCESSWIRE
BioLargo Achieves 111% Growth to a Record $1.5 Million Revenue for Third Quarter 2022
Via ACCESSWIRE
BioLargo Achieves 185% Growth to $1.3 Million Revenue for Second Quarter 2022, as Published in Quarterly Report
Via ACCESSWIRE
BioLargo Sets New Quarterly Revenue Record
Via ACCESSWIRE
BioLargo Q3 2022 Earnings Results Webcast and Conference Call on Wednesday, November 16, 2022 - 5 PM Eastern Time
Via ACCESSWIRE
Results from BioLargo's 18-Month Municipal Wastewater Treatment Pilot in Montreal Presented at National Conference
Via ACCESSWIRE
BioLargo Adds Linda Park and Christina Bray to Board of Directors
Via ACCESSWIRE
BioLargo Sets Another New Quarterly Revenue Record
Via ACCESSWIRE
BioLargo, Inc. Discusses Its PFAS Treatment Solution and Odor Control Technology with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - October 25, 2022) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that... 
Via Newsfile
BioLargo Secures Product Recovery Management (PRM) as Channel Partner and Contract Manufacturer for BioLargo’s Water Treatment Technologies
Via ACCESSWIRE
BioLargo Q2 2022 Earnings Results Webcast and Conference Call on Wednesday, August 17, 2022 - 4 PM Eastern Time
Via ACCESSWIRE
BioLargo Secures First PFAS Mitigation Customer and Signs New Channel Partner for PFAS Remediation
Via ACCESSWIRE
BioLargo Engineering, Science & Technologies Selected to Help Make Novel Nuclear Reactor Fuel Production System
WESTMINSTER, CA / ACCESSWIRE / June 30, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that its... 
From BioLargo, Inc.
Via AccessWire
BioLargo, Inc. Discusses Record-Breaking Quarter on The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - May 23, 2022) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that... 
Via Newsfile
BioLargo Q1 2022 Earnings Results Webcast and Conference Call on Thursday, May 19, 2022 - 4:00 PM Eastern Time
WESTMINSTER, CA / ACCESSWIRE / May 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of cleantech technologies and full-service environmental engineering company, announced it will host an investor... 
From BioLargo, Inc.
Via AccessWire
BioLargo's First Quarterly Report of 2022 Highlights: Record Company-wide Revenues, Subsidiaries Achieving and Approaching Profitability, and Progress of Key Growth Catalysts
WESTMINSTER, CA / ACCESSWIRE / May 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Quarterly... 
From BioLargo, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
BioLargo Continues Growth Trend by Breaking Quarterly Revenue Record
WESTMINSTER, CA / ACCESSWIRE / April 20, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, today announced a... 
From BioLargo, Inc.
Via AccessWire
BioLargo Annual Earnings Results Webcast and Conference Call Monday, April 4, 2022 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESSWIRE / April 1, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, will host an investor webcast and... 
From BioLargo, Inc.
Via AccessWire
BioLargo Annual Report for 2021 Highlights Active Commercial Catalysts, Expanding Partnerships, and Improved Balance Sheet
WESTMINSTER, CA / ACCESSWIRE / March 31, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Annual... 
From BioLargo, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
BioLargo Provides Progress Report on Major Growth Catalysts
WESTMINSTER, CA / ACCESSWIRE / February 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, today provided an... 
From BioLargo, Inc.
Via AccessWire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.